HomeEVMN • NYSE
add
Evommune Inc
Previous close
$16.00
Day range
$16.70 - $20.66
Year range
$16.70 - $20.66
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.99M | -18.72% |
Net income | -13.56M | 50.46% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -22.62M | 19.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.80M | — |
Total assets | 96.21M | — |
Total liabilities | 10.44M | — |
Total equity | 85.77M | — |
Shares outstanding | 13.25M | — |
Price to book | -1.24 | — |
Return on assets | -75.53% | — |
Return on capital | -94.89% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -13.56M | 50.46% |
Cash from operations | -26.21M | -203.83% |
Cash from investing | 18.00M | 79.52% |
Cash from financing | 64.34M | 59,675.00% |
Net change in cash | 56.13M | 4,241.30% |
Free cash flow | -27.36M | — |
About
Founded
2020
Headquarters
Website
Employees
45
